Browse the evidence

MitoQ supplementation did not alter acute exercise-induced redox responses in skeletal muscle.

MitoQ does not affect redox signaling during acute exercise in older adults.

HbA1C levels increase alongside the duration of illness in individuals with type 2 diabetes.

Practitioners should monitor HbA1C levels to assess disease progression in diabetic patients.

Observational data suggest GLP-1 RAs improve walking distance in peripheral artery disease.

GLP-1 RAs may enhance mobility in patients with peripheral artery disease.

Nutritional therapists are too rarely consulted despite the significant effects of diet on cardiovascular risk factors.

Practitioners should consider involving nutritional therapists in treatment plans for dyslipidemias.

Tirzepatide may result in an increase in non-serious adverse events (risk ratio 1.33, 95% CI 1.03 to 1.71) compared to placebo.

Clinicians should monitor for non-serious adverse events when prescribing tirzepatide.

Incretin therapies could ameliorate fatty liver disease, chronic inflammation, sleep apnea, and possibly degenerative bone disorders and cognitive decline.

Incretin therapies may be considered for patients with these co-morbidities, pending further research.

Baseline disease severity, depressive symptoms, insulin resistance, and preperitoneal fat were negatively associated with PASI improvement.

Understanding these associations can help tailor treatment strategies for better outcomes.

Tirzepatide may have potential therapeutic effects on metabolic dysfunction-associated steatohepatitis (MASH).

Tirzepatide could be explored as a treatment option for patients with MASH, pending further research.

Collagen supplements may be useful to reduce tendon and ligament injuries in volleyball.

Consider recommending collagen supplementation for volleyball athletes to potentially reduce injury risk.